8-K: Philip Morris International Announces Quarterly Dividend of $1.30 Per Share

Philip Morris International declared a regular quarterly dividend of $1.30 per common share, payable on July 8, 2024, to shareholders of record as of June 21, 2024.

Summary

• Philip Morris International (PMI) has announced a regular quarterly dividend of $1.30 per common share.
• The dividend is payable on July 8, 2024, to shareholders of record as of June 21, 2024.
• The ex-dividend date is also June 21, 2024.
• PMI is focused on delivering a smoke-free future and is expanding its portfolio beyond tobacco and nicotine.
• The company has invested over $12.5 billion since 2008 in developing and commercializing smoke-free products.
• PMI's smoke-free products were available in 84 markets as of December 31, 2023.
• Approximately 33 million adults globally use PMI's smoke-free products.
• Smoke-free products accounted for about 37% of PMI's total net revenues in 2023.
• PMI acquired Swedish Match in 2022, creating a global smoke-free champion.
• PMI is expanding into wellness and healthcare through its Vectura Fertin Pharma business.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the consistent dividend payout, the company's focus on smoke-free products, and its expansion into new sectors. The lack of negative news or risks mentioned contributes to the high score.

Positives

• The declaration of a regular quarterly dividend of $1.30 per share provides a return to shareholders.
• PMI's significant investment of over $12.5 billion in smoke-free products demonstrates a commitment to innovation and future growth.
• The availability of smoke-free products in 84 markets indicates a strong global presence.
• The 37% contribution of smoke-free products to total net revenues in 2023 shows a growing shift towards these products.
• The acquisition of Swedish Match positions PMI as a leader in the smoke-free market.
• PMI's expansion into wellness and healthcare through Vectura Fertin Pharma diversifies its business and opens new growth opportunities.

Risks

• The document does not explicitly mention any risks, but the tobacco industry faces regulatory and public health challenges.
• The transition to smoke-free products may face consumer adoption hurdles and competition.
• The expansion into wellness and healthcare may present operational and market risks.

Future Outlook

PMI aims to deliver a smoke-free future and expand its portfolio beyond tobacco and nicotine, including wellness and healthcare.

Management Comments

• PMI is actively delivering a smoke-free future and evolving its portfolio for the long term.
• PMI aims to completely end the sale of cigarettes.
• PMI is expanding into wellness and healthcare areas through its Vectura Fertin Pharma business.

Industry Context

The announcement aligns with the broader industry trend of tobacco companies diversifying into smoke-free products and other sectors due to declining cigarette sales and increasing health concerns.

Comparison to Industry Standards

• Other major tobacco companies like British American Tobacco and Imperial Brands are also investing in smoke-free alternatives, but PMI's focus on scientific substantiation and its acquisition of Swedish Match position it as a leader in this space.
• PMI's 37% revenue contribution from smoke-free products is a significant figure compared to some competitors, indicating a more advanced transition.
• The investment of $12.5 billion in smoke-free products is a substantial commitment, potentially exceeding the investments of some peers.

Stakeholder Impact

• Shareholders will receive a regular quarterly dividend of $1.30 per share.
• Employees may benefit from the company's growth in new sectors.
• Customers will have access to a wider range of smoke-free products.
• Suppliers may see increased demand for components used in smoke-free products.
• Creditors may view the company's diversification as a positive sign.

Next Steps

• The dividend will be paid on July 8, 2024.
• PMI will continue to develop and commercialize smoke-free products.
• PMI will continue to expand into wellness and healthcare areas.

Key Dates

Keywords

dividend, smoke-free products, Philip Morris International, tobacco, Swedish Match, IQOS, ZYN, Vectura Fertin Pharma, wellness, healthcare